Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jul 27, 2026; 18(7): 119397
Published online Jul 27, 2026. doi: 10.4240/wjgs.v18.i7.119397
Published online Jul 27, 2026. doi: 10.4240/wjgs.v18.i7.119397
Table 1 Basic data of the patients, n (%)/mean ± SD
| Variables | Combination group | TACE group | t/χ2 | P value |
| Gender (male/female) | 37 (47.44)/41 (52.56) | 24 (57.14)/18 (42.86) | 1.029 | 0.310 |
| Mean age (years) | 59.14 ± 8.06 | 57.93 ± 7.01 | 0.821 | 0.413 |
| Duration of hepatitis B infection (year) | 19.22 ± 2.41 | 17.01 ± 3.12 | 3.214 | 0.142 |
| Tumor size (cm) | 4.39 ± 2.50 | 3.99 ± 1.24 | 2.581 | 0.093 |
| Tumor location (left lobe/right lobe/multifocal, %) | 33.62/59.18/7.20% | 32.12/59.18/8.70% | 1.892 | 0.059 |
- Citation: Xia Q, Shan W, Yan H. Clinical and radiomic characteristics of transarterial chemoembolization combined with immunotherapy in hepatocellular carcinoma. World J Gastrointest Surg 2026; 18(7): 119397
- URL: https://www.wjgnet.com/1948-9366/full/v18/i7/119397.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i7.119397